GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Molecular Mechanisms of Neoplastic Transformation in Human Cells

$250,570
Christopher M Counter · Duke University · R01 · FY2011 · CA

Myt1 Function for Endocrine Islet Development & Fuction

$250,557
Guoqiang Gu · Vanderbilt University · R01 · FY2007 · DK

PDX Core

$250,511
Bingliang Fang · University Of Tx Md Anderson Can Ctr · U54 · FY2019 · CA

Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer

$250,509
Jason B Fleming · University Of Tx Md Anderson Can Ctr · U54 · FY2019 · CA

Keratin 19 and Pancreatic Ductal Biology

$250,471
Anil K Rustgi · University Of Pennsylvania · R01 · FY2006 · DK

Role of Mineralocorticoids in Hypertension

$250,470
Celso Enrique Gomez-Sanchez · University Of Mississippi Med Ctr · R01 · FY2012 · HL

Kinase Imaging

$250,430
Lee Josephson · Massachusetts General Hospital · P50 · FY2010 · CA

Mouse Model for Human Pancreatic Ductal Adenocarcinoma

$250,358
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2011 · CA

Mouse Model for Human Pancreatic Ductal Adenocarcinoma

$250,358
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2007 · CA

Mouse Model for Human Pancreatic Ductal Adenocarcinoma

$250,358
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2008 · CA

Mouse Model for Human Pancreatic Ductal Adenocarcinoma

$250,358
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2015 · CA

THE ROLE OF TSNA IN PANCREATIC CANCER

$250,351
Bogdan Prokopczyk · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2006 · CA

Development of small molecule inhibitors of ULK1

$250,290
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR

IAPs As Novel Targets for Cancer Therapy

$250,230
Emory University · R01 · FY2004 · CA

EXOSOME-MEDIATED THROMBOSIS IN PANCREATIC CANCER

$250,188
Weill Medical College Of Cornell University · · FY2020 · Defense Health Agency

Discovery of combination therapy for KRAS mutant cancer

$250,129
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Molecular determinants of A-site mRNA cleavage during ribosome pausing

$250,113
Christopher S. Hayes · University Of California Santa Barbara · R01 · FY2008 · GM

EORTC HEADQUARTERS

$250,025
Denis Lacombe · European Org/Res/Treatment/Cancer · U10 · FY2013 · CA

EORTC HEADQUARTERS

$250,025
Denis Lacombe · European Org/Res/Treatment/Cancer · U10 · FY2015 · CA

Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer

$250,024
Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2022 · CA

Nanostructured Matrices for Cancer Cell Biology

$250,020
Milan Mrksich · Northwestern University At Chicago · U54 · FY2013 · CA

SPORE in Gastrointestinal Cancer

$250,000
Scott E Kern · Johns Hopkins University · P50 · FY2006 · CA

Ph1 Study of T-Vec given endoscopically for advanced pancreatic cancer IN 17248 (11/21/2016)

$250,000
Yvonne Margaret Saenger · Columbia University Health Sciences · R01 · FY2020 · FD

Comprehensive Cancer Center Core Support Grant

$250,000
Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2008 · CA

Stopping PDA progression using inhibitors of CSC dissemination and immunotherapy

$250,000
Sunil R Hingorani · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA